Clinical Trials Insight: 700044859

Trial Profile

Clinical Trials Insight: 700044859

Completed
Phase of Trial: Phase I

Latest Information Update: 16 Jul 2009

At a glance

  • Drugs EP 42675 (Primary)
  • Indications Acute coronary syndromes; Thrombosis
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Sponsors Endotis Pharma
  • Most Recent Events

    • 16 Jul 2009 Results reported at the 22nd Congress of the International Society on Thrombosis and Haemostasis.
    • 26 May 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top